Aberrant intracellular IGF-1R beta-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation. (Q39870166)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Aberrant intracellular IGF-1R beta-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Natalia Natalishvili

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Magnus Axelson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Olle Larsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Daiana Vasilcanu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

English

0 references

publication date

23 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

1458-1467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

Structure and function of the type 1 insulin-like growth factor receptor.

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

The contradictions of the insulin-like growth factor 1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

The IGF-I receptor in cell growth, transformation and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

The IGF‐1 receptor in cancer biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Role of insulin-like growth factor 1 receptor signalling in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

The three dimensional structure of the type I insulin-like growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

IGF1R signalling and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Insulin-like growth factors and neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R-).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Insulin-like growth factor-I is an important antiapoptotic factor for rat leydig cells during postnatal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Estradiol-17beta regulates mouse uterine epithelial cell proliferation through insulin-like growth factor 1 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Insulin growth factor signaling mediates neuron-like differentiation of adipose-tissue-derived stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Transformation of late passage insulin-like growth factor-I receptor null mouse embryo fibroblasts by SV40 T antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Insulin-like growth factor I receptor signaling in transformation by src oncogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

The constitutively active mutant Galpha13 transforms mouse fibroblast cells deficient in insulin-like growth factor-I receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Phosphorylation by Akt disables the anti-oncogenic activity of YB-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Ubiquitin-dependent degradation of active Src.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

A familial insulin-like growth factor-I receptor mutant leads to short stature: clinical and biochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Expression of insulin-like growth factor-I receptor in primary cutaneous carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Expression and distribution of IGF-1 receptors containing a beta-subunit variant (betagc) in developing neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.01.008

10.1016/J.YEXCR.2009.01.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19302825%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference